Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Incidence of the different stages of status epilepticus in Eastern Finland: A population-based study.

Kantanen AM, Sairanen J, Kälviäinen R.

Epilepsy Behav. 2019 Jul 29:106413. doi: 10.1016/j.yebeh.2019.07.014. [Epub ahead of print]

2.

Management of prolonged epileptic seizures and status epilepticus in palliative care patients.

Kälviäinen R, Reinikainen M.

Epilepsy Behav. 2019 May 24. pii: S1525-5050(19)30372-5. doi: 10.1016/j.yebeh.2019.04.041. [Epub ahead of print] Review.

PMID:
31133511
3.

Treatment delay in status epilepticus - more effective prehospital symptom recognition warranted.

Sairanen JJ, Kantanen AM, Hyppölä HT, Kälviäinen RK.

Scand J Trauma Resusc Emerg Med. 2019 Mar 7;27(1):28. doi: 10.1186/s13049-019-0605-7.

4.

Perampanel for treatment of status epilepticus in Austria, Finland, Germany, and Spain.

Strzelczyk A, Knake S, Kälviäinen R, Santamarina E, Toledo M, Willig S, Rohracher A, Trinka E, Rosenow F.

Acta Neurol Scand. 2019 Apr;139(4):369-376. doi: 10.1111/ane.13061. Epub 2019 Jan 20.

5.

Variants p.Q1236H and p.E1143G in mitochondrial DNA polymerase gamma POLG1 are not associated with increased risk for valproate-induced hepatotoxicity or pancreatic toxicity: A retrospective cohort study of patients with epilepsy.

Hynynen J, Pokka T, Komulainen-Ebrahim J, Myllynen P, Kärppä M, Pylvänen L, Kälviäinen R, Sokka A, Jyrkilä A, Lähdetie J, Haataja L, Mäkitalo A, Ylikotila P, Eriksson K, Haapala P, Ansakorpi H, Hinttala R, Vieira P, Majamaa K, Rantala H, Uusimaa J.

Epilepsia. 2018 Nov;59(11):2125-2136. doi: 10.1111/epi.14568. Epub 2018 Sep 26.

PMID:
30255931
6.

No Evidence of a Causal Role of Antiepileptic Drug Treatment with Regard to the Development of Dementia.

Helmstaedter C, Beghi E, Elger CE, Kälviäinen R, Malmgren K, May TW, Perucca E, Trinka E, Witt JA.

J Am Geriatr Soc. 2018 Sep;66(9):1850-1852. doi: 10.1111/jgs.15467. Epub 2018 Aug 9. No abstract available.

PMID:
30094813
7.

Analysis of shared heritability in common disorders of the brain.

Brainstorm Consortium, Anttila V, Bulik-Sullivan B, Finucane HK, Walters RK, Bras J, Duncan L, Escott-Price V, Falcone GJ, Gormley P, Malik R, Patsopoulos NA, Ripke S, Wei Z, Yu D, Lee PH, Turley P, Grenier-Boley B, Chouraki V, Kamatani Y, Berr C, Letenneur L, Hannequin D, Amouyel P, Boland A, Deleuze JF, Duron E, Vardarajan BN, Reitz C, Goate AM, Huentelman MJ, Kamboh MI, Larson EB, Rogaeva E, St George-Hyslop P, Hakonarson H, Kukull WA, Farrer LA, Barnes LL, Beach TG, Demirci FY, Head E, Hulette CM, Jicha GA, Kauwe JSK, Kaye JA, Leverenz JB, Levey AI, Lieberman AP, Pankratz VS, Poon WW, Quinn JF, Saykin AJ, Schneider LS, Smith AG, Sonnen JA, Stern RA, Van Deerlin VM, Van Eldik LJ, Harold D, Russo G, Rubinsztein DC, Bayer A, Tsolaki M, Proitsi P, Fox NC, Hampel H, Owen MJ, Mead S, Passmore P, Morgan K, Nöthen MM, Rossor M, Lupton MK, Hoffmann P, Kornhuber J, Lawlor B, McQuillin A, Al-Chalabi A, Bis JC, Ruiz A, Boada M, Seshadri S, Beiser A, Rice K, van der Lee SJ, De Jager PL, Geschwind DH, Riemenschneider M, Riedel-Heller S, Rotter JI, Ransmayr G, Hyman BT, Cruchaga C, Alegret M, Winsvold B, Palta P, Farh KH, Cuenca-Leon E, Furlotte N, Kurth T, Ligthart L, Terwindt GM, Freilinger T, Ran C, Gordon SD, Borck G, Adams HHH, Lehtimäki T, Wedenoja J, Buring JE, Schürks M, Hrafnsdottir M, Hottenga JJ, Penninx B, Artto V, Kaunisto M, Vepsäläinen S, Martin NG, Montgomery GW, Kurki MI, Hämäläinen E, Huang H, Huang J, Sandor C, Webber C, Muller-Myhsok B, Schreiber S, Salomaa V, Loehrer E, Göbel H, Macaya A, Pozo-Rosich P, Hansen T, Werge T, Kaprio J, Metspalu A, Kubisch C, Ferrari MD, Belin AC, van den Maagdenberg AMJM, Zwart JA, Boomsma D, Eriksson N, Olesen J, Chasman DI, Nyholt DR, Avbersek A, Baum L, Berkovic S, Bradfield J, Buono RJ, Catarino CB, Cossette P, De Jonghe P, Depondt C, Dlugos D, Ferraro TN, French J, Hjalgrim H, Jamnadas-Khoda J, Kälviäinen R, Kunz WS, Lerche H, Leu C, Lindhout D, Lo W, Lowenstein D, McCormack M, Møller RS, Molloy A, Ng PW, Oliver K, Privitera M, Radtke R, Ruppert AK, Sander T, Schachter S, Schankin C, Scheffer I, Schoch S, Sisodiya SM, Smith P, Sperling M, Striano P, Surges R, Thomas GN, Visscher F, Whelan CD, Zara F, Heinzen EL, Marson A, Becker F, Stroink H, Zimprich F, Gasser T, Gibbs R, Heutink P, Martinez M, Morris HR, Sharma M, Ryten M, Mok KY, Pulit S, Bevan S, Holliday E, Attia J, Battey T, Boncoraglio G, Thijs V, Chen WM, Mitchell B, Rothwell P, Sharma P, Sudlow C, Vicente A, Markus H, Kourkoulis C, Pera J, Raffeld M, Silliman S, Boraska Perica V, Thornton LM, Huckins LM, William Rayner N, Lewis CM, Gratacos M, Rybakowski F, Keski-Rahkonen A, Raevuori A, Hudson JI, Reichborn-Kjennerud T, Monteleone P, Karwautz A, Mannik K, Baker JH, O'Toole JK, Trace SE, Davis OSP, Helder SG, Ehrlich S, Herpertz-Dahlmann B, Danner UN, van Elburg AA, Clementi M, Forzan M, Docampo E, Lissowska J, Hauser J, Tortorella A, Maj M, Gonidakis F, Tziouvas K, Papezova H, Yilmaz Z, Wagner G, Cohen-Woods S, Herms S, Julià A, Rabionet R, Dick DM, Ripatti S, Andreassen OA, Espeseth T, Lundervold AJ, Steen VM, Pinto D, Scherer SW, Aschauer H, Schosser A, Alfredsson L, Padyukov L, Halmi KA, Mitchell J, Strober M, Bergen AW, Kaye W, Szatkiewicz JP, Cormand B, Ramos-Quiroga JA, Sánchez-Mora C, Ribasés M, Casas M, Hervas A, Arranz MJ, Haavik J, Zayats T, Johansson S, Williams N, Dempfle A, Rothenberger A, Kuntsi J, Oades RD, Banaschewski T, Franke B, Buitelaar JK, Arias Vasquez A, Doyle AE, Reif A, Lesch KP, Freitag C, Rivero O, Palmason H, Romanos M, Langley K, Rietschel M, Witt SH, Dalsgaard S, Børglum AD, Waldman I, Wilmot B, Molly N, Bau CHD, Crosbie J, Schachar R, Loo SK, McGough JJ, Grevet EH, Medland SE, Robinson E, Weiss LA, Bacchelli E, Bailey A, Bal V, Battaglia A, Betancur C, Bolton P, Cantor R, Celestino-Soper P, Dawson G, De Rubeis S, Duque F, Green A, Klauck SM, Leboyer M, Levitt P, Maestrini E, Mane S, De-Luca DM, Parr J, Regan R, Reichenberg A, Sandin S, Vorstman J, Wassink T, Wijsman E, Cook E, Santangelo S, Delorme R, Rogé B, Magalhaes T, Arking D, Schulze TG, Thompson RC, Strohmaier J, Matthews K, Melle I, Morris D, Blackwood D, McIntosh A, Bergen SE, Schalling M, Jamain S, Maaser A, Fischer SB, Reinbold CS, Fullerton JM, Guzman-Parra J, Mayoral F, Schofield PR, Cichon S, Mühleisen TW, Degenhardt F, Schumacher J, Bauer M, Mitchell PB, Gershon ES, Rice J, Potash JB, Zandi PP, Craddock N, Ferrier IN, Alda M, Rouleau GA, Turecki G, Ophoff R, Pato C, Anjorin A, Stahl E, Leber M, Czerski PM, Cruceanu C, Jones IR, Posthuma D, Andlauer TFM, Forstner AJ, Streit F, Baune BT, Air T, Sinnamon G, Wray NR, MacIntyre DJ, Porteous D, Homuth G, Rivera M, Grove J, Middeldorp CM, Hickie I, Pergadia M, Mehta D, Smit JH, Jansen R, de Geus E, Dunn E, Li QS, Nauck M, Schoevers RA, Beekman AT, Knowles JA, Viktorin A, Arnold P, Barr CL, Bedoya-Berrio G, Bienvenu OJ, Brentani H, Burton C, Camarena B, Cappi C, Cath D, Cavallini M, Cusi D, Darrow S, Denys D, Derks EM, Dietrich A, Fernandez T, Figee M, Freimer N, Gerber G, Grados M, Greenberg E, Hanna GL, Hartmann A, Hirschtritt ME, Hoekstra PJ, Huang A, Huyser C, Illmann C, Jenike M, Kuperman S, Leventhal B, Lochner C, Lyon GJ, Macciardi F, Madruga-Garrido M, Malaty IA, Maras A, McGrath L, Miguel EC, Mir P, Nestadt G, Nicolini H, Okun MS, Pakstis A, Paschou P, Piacentini J, Pittenger C, Plessen K, Ramensky V, Ramos EM, Reus V, Richter MA, Riddle MA, Robertson MM, Roessner V, Rosário M, Samuels JF, Sandor P, Stein DJ, Tsetsos F, Van Nieuwerburgh F, Weatherall S, Wendland JR, Wolanczyk T, Worbe Y, Zai G, Goes FS, McLaughlin N, Nestadt PS, Grabe HJ, Depienne C, Konkashbaev A, Lanzagorta N, Valencia-Duarte A, Bramon E, Buccola N, Cahn W, Cairns M, Chong SA, Cohen D, Crespo-Facorro B, Crowley J, Davidson M, DeLisi L, Dinan T, Donohoe G, Drapeau E, Duan J, Haan L, Hougaard D, Karachanak-Yankova S, Khrunin A, Klovins J, Kučinskas V, Lee Chee Keong J, Limborska S, Loughland C, Lönnqvist J, Maher B, Mattheisen M, McDonald C, Murphy KC, Nenadic I, van Os J, Pantelis C, Pato M, Petryshen T, Quested D, Roussos P, Sanders AR, Schall U, Schwab SG, Sim K, So HC, Stögmann E, Subramaniam M, Toncheva D, Waddington J, Walters J, Weiser M, Cheng W, Cloninger R, Curtis D, Gejman PV, Henskens F, Mattingsdal M, Oh SY, Scott R, Webb B, Breen G, Churchhouse C, Bulik CM, Daly M, Dichgans M, Faraone SV, Guerreiro R, Holmans P, Kendler KS, Koeleman B, Mathews CA, Price A, Scharf J, Sklar P, Williams J, Wood NW, Cotsapas C, Palotie A, Smoller JW, Sullivan P, Rosand J, Corvin A, Neale BM, Schott JM, Anney R, Elia J, Grigoroiu-Serbanescu M, Edenberg HJ, Murray R.

Science. 2018 Jun 22;360(6395). pii: eaap8757. doi: 10.1126/science.aap8757.

8.

Reducing valproate use in women with epilepsy.

Kälviäinen R, Straus S, Dogne JM, Bakchine S, Haas M.

Lancet Neurol. 2018 Jul;17(7):580-581. doi: 10.1016/S1474-4422(18)30172-8. No abstract available.

PMID:
29914703
9.

Comparable indicators of therapeutic misconception between epilepsy or Parkinson's disease patients between those with clinical trial experience and trial non-participants.

Reijula E, Halkoaho A, Pietilä AM, Selander T, Martikainen K, Kälviäinen R, Keränen T.

Seizure. 2018 Aug;60:61-67. doi: 10.1016/j.seizure.2018.06.006. Epub 2018 Jun 9.

10.

European trends in epilepsy surgery.

Baud MO, Perneger T, Rácz A, Pensel MC, Elger C, Rydenhag B, Malmgren K, Cross JH, McKenna G, Tisdall M, Lamberink HJ, Rheims S, Ryvlin P, Isnard J, Mauguière F, Arzimanoglou A, Akkol S, Deniz K, Ozkara C, Lossius M, Rektor I, Kälviäinen R, Vanhatalo LM, Dimova P, Minkin K, Staack AM, Steinhoff BJ, Kalina A, Krsek P, Marusic P, Jordan Z, Fabo D, Carrette E, Boon P, Rocka S, Mameniškienė R, Vulliemoz S, Pittau F, Braun KPJ, Seeck M.

Neurology. 2018 Jul 10;91(2):e96-e106. doi: 10.1212/WNL.0000000000005776. Epub 2018 Jun 13.

PMID:
29898967
11.

No proof of a causal relationship between antiepileptic drug treatment and incidence of dementia. Comment on: Use of antiepileptic drugs and dementia risk-An analysis of Finnish health register and German health insurance data.

Helmstaedter C, Beghi E, Elger CE, Kälviäinen R, Malmgren K, May TW, Perucca E, Trinka E, Witt JA.

Epilepsia. 2018 Jul;59(7):1303-1306. doi: 10.1111/epi.14432. Epub 2018 May 28. No abstract available.

12.

Abnormal motor cortical adaptation to external stimulus in Unverricht-Lundborg disease (progressive myoclonus type 1, EPM1).

Julkunen P, Löfberg O, Kallioniemi E, Hyppönen J, Kälviäinen R, Mervaala E.

J Neurophysiol. 2018 Aug 1;120(2):617-623. doi: 10.1152/jn.00063.2018. Epub 2018 May 9.

13.

Antiepileptic drug treatment of generalized tonic-clonic seizures: An evaluation of regulatory data and five criteria for drug selection.

Shorvon SD, Bermejo PE, Gibbs AA, Huberfeld G, Kälviäinen R.

Epilepsy Behav. 2018 May;82:91-103. doi: 10.1016/j.yebeh.2018.01.039. Epub 2018 Mar 27. Review.

PMID:
29602083
14.

Declining trend in valproate use in Finland among females of childbearing age in 2012-2016 - a nationwide registry-based outpatient study.

Virta LJ, Kälviäinen R, Villikka K, Keränen T.

Eur J Neurol. 2018 Jun;25(6):869-874. doi: 10.1111/ene.13610. Epub 2018 Mar 31.

PMID:
29509301
15.

Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study.

Whelan CD, Altmann A, Botía JA, Jahanshad N, Hibar DP, Absil J, Alhusaini S, Alvim MKM, Auvinen P, Bartolini E, Bergo FPG, Bernardes T, Blackmon K, Braga B, Caligiuri ME, Calvo A, Carr SJ, Chen J, Chen S, Cherubini A, David P, Domin M, Foley S, França W, Haaker G, Isaev D, Keller SS, Kotikalapudi R, Kowalczyk MA, Kuzniecky R, Langner S, Lenge M, Leyden KM, Liu M, Loi RQ, Martin P, Mascalchi M, Morita ME, Pariente JC, Rodríguez-Cruces R, Rummel C, Saavalainen T, Semmelroch MK, Severino M, Thomas RH, Tondelli M, Tortora D, Vaudano AE, Vivash L, von Podewils F, Wagner J, Weber B, Yao Y, Yasuda CL, Zhang G, Bargalló N, Bender B, Bernasconi N, Bernasconi A, Bernhardt BC, Blümcke I, Carlson C, Cavalleri GL, Cendes F, Concha L, Delanty N, Depondt C, Devinsky O, Doherty CP, Focke NK, Gambardella A, Guerrini R, Hamandi K, Jackson GD, Kälviäinen R, Kochunov P, Kwan P, Labate A, McDonald CR, Meletti S, O'Brien TJ, Ourselin S, Richardson MP, Striano P, Thesen T, Wiest R, Zhang J, Vezzani A, Ryten M, Thompson PM, Sisodiya SM.

Brain. 2018 Feb 1;141(2):391-408. doi: 10.1093/brain/awx341.

16.

Clinical features of Parkinson's disease patients are associated with therapeutic misconception and willingness to participate in clinical trials.

Reijula E, Pietilä AM, Halkoaho A, Selander T, Martikainen K, Kälviäinen R, Keränen T.

Trials. 2017 Sep 29;18(1):444. doi: 10.1186/s13063-017-2174-2.

17.

Co-morbidity and clinically significant interactions between antiepileptic drugs and other drugs in elderly patients with newly diagnosed epilepsy.

Bruun E, Virta LJ, Kälviäinen R, Keränen T.

Epilepsy Behav. 2017 Aug;73:71-76. doi: 10.1016/j.yebeh.2017.05.022. Epub 2017 Jun 14.

PMID:
28622547
18.

Epilepsy-associated long-term mortality after aneurysmal subarachnoid hemorrhage.

Huttunen J, Lindgren A, Kurki MI, Huttunen T, Frösen J, Koivisto T, von Und Zu Fraunberg M, Immonen A, Jääskeläinen JE, Kälviäinen R.

Neurology. 2017 Jul 18;89(3):263-268. doi: 10.1212/WNL.0000000000004113. Epub 2017 Jun 14.

19.

European Stroke Organisation guidelines for the management of post-stroke seizures and epilepsy.

Holtkamp M, Beghi E, Benninger F, Kälviäinen R, Rocamora R, Christensen H; European Stroke Organisation.

Eur Stroke J. 2017 Jun;2(2):103-115. doi: 10.1177/2396987317705536. Epub 2017 Apr 19.

20.

Long-term outcome of refractory status epilepticus in adults: A retrospective population-based study.

Kantanen AM, Reinikainen M, Parviainen I, Kälviäinen R.

Epilepsy Res. 2017 Jul;133:13-21. doi: 10.1016/j.eplepsyres.2017.03.009. Epub 2017 Apr 2.

21.

Predictors of hospital and one-year mortality in intensive care patients with refractory status epilepticus: a population-based study.

Kantanen AM, Kälviäinen R, Parviainen I, Ala-Peijari M, Bäcklund T, Koskenkari J, Laitio R, Reinikainen M.

Crit Care. 2017 Mar 23;21(1):71. doi: 10.1186/s13054-017-1661-x.

22.

Etiology, syndrome diagnosis, and cognition in childhood-onset epilepsy: A population-based study.

Sokka A, Olsen P, Kirjavainen J, Harju M, Keski-Nisula L, Räisänen S, Heinonen S, Kälviäinen R.

Epilepsia Open. 2017 Jan 19;2(1):76-83. doi: 10.1002/epi4.12036. eCollection 2017 Mar.

23.

Current standards of neuropsychological assessment in epilepsy surgery centers across Europe.

Vogt VL, Äikiä M, Del Barrio A, Boon P, Borbély C, Bran E, Braun K, Carette E, Clark M, Cross JH, Dimova P, Fabo D, Foroglou N, Francione S, Gersamia A, Gil-Nagel A, Guekht A, Harrison S, Hecimovic H, Heminghyt E, Hirsch E, Javurkova A, Kälviäinen R, Kavan N, Kelemen A, Kimiskidis VK, Kirschner M, Kleitz C, Kobulashvili T, Kosmidis MH, Kurtish SY, Lesourd M, Ljunggren S, Lossius MI, Malmgren K, Mameniskiené R, Martin-Sanfilippo P, Marusic P, Miatton M, Özkara Ç, Pelle F, Rubboli G, Rudebeck S, Ryvlin P, van Schooneveld M, Schmid E, Schmidt PM, Seeck M, Steinhoff BJ, Shavel-Jessop S, Tarta-Arsene O, Trinka E, Viggedal G, Wendling AS, Witt JA, Helmstaedter C; E-PILEPSY consortium.

Epilepsia. 2017 Mar;58(3):343-355. doi: 10.1111/epi.13646. Epub 2017 Jan 9.

24.

TMS combined with EEG in genetic generalized epilepsy: A phase II diagnostic accuracy study.

Kimiskidis VK, Tsimpiris A, Ryvlin P, Kalviainen R, Koutroumanidis M, Valentin A, Laskaris N, Kugiumtzis D.

Clin Neurophysiol. 2017 Feb;128(2):367-381. doi: 10.1016/j.clinph.2016.11.013. Epub 2016 Nov 24.

PMID:
28007469
25.

25 years of advances in the definition, classification and treatment of status epilepticus.

Trinka E, Kälviäinen R.

Seizure. 2017 Jan;44:65-73. doi: 10.1016/j.seizure.2016.11.001. Epub 2016 Nov 14. Review.

26.

Outcome of initial antiepileptic drug treatment in elderly patients with newly diagnosed epilepsy.

Bruun E, Kälviäinen R, Keränen T.

Epilepsy Res. 2016 Nov;127:60-65. doi: 10.1016/j.eplepsyres.2016.08.023. Epub 2016 Aug 20.

PMID:
27565412
27.

Myoclonus and seizures in progressive myoclonus epilepsies: pharmacology and therapeutic trials.

Michelucci R, Pasini E, Riguzzi P, Andermann E, Kälviäinen R, Genton P.

Epileptic Disord. 2016 Sep 1;18(S2):145-153. Review.

PMID:
27629998
28.

Unverricht-Lundborg disease.

Crespel A, Ferlazzo E, Franceschetti S, Genton P, Gouider R, Kälviäinen R, Korja M, Lehtinen MK, Mervaala E, Simonato M, Vaarmann A.

Epileptic Disord. 2016 Sep 1;18(S2):28-37. Review.

PMID:
27582036
29.

Antidepressant Use After Aneurysmal Subarachnoid Hemorrhage: A Population-Based Case-Control Study.

Huttunen J, Lindgren A, Kurki MI, Huttunen T, Frösen J, von Und Zu Fraunberg M, Koivisto T, Kälviäinen R, Räikkönen K, Viinamäki H, Jääskeläinen JE, Immonen A.

Stroke. 2016 Sep;47(9):2242-8. doi: 10.1161/STROKEAHA.116.014327. Epub 2016 Aug 2.

PMID:
27486167
30.

The future of medicine will be dark without international collaboration [corrected].

Reuber M, Helmstaedter C, Liao W, Loddenkemper T, Thomas R, Kälviäinen R, Mann M.

Seizure. 2016 Oct;41:42. doi: 10.1016/j.seizure.2016.07.009. Epub 2016 Jul 21. No abstract available. Erratum in: Seizure. 2016 Dec;43:69.

31.

Testing of Triggers by Data Mining of Epilepsy Patients' Structured Nursing Records.

Kinnunen UM, Kivekäs E, Paananen P, Kälviäinen R, Saranto K.

Stud Health Technol Inform. 2016;225:461-5.

PMID:
27332243
32.

Functionality of Triggers for Epilepsy Patients Assessed by Text and Data Mining of Medical and Nursing Records.

Kivekäs E, Kinnunen UM, Paananen P, Kälviäinen R, Haatainen K, Saranto K.

Stud Health Technol Inform. 2016;225:128-32.

PMID:
27332176
33.

Current practices in long-term video-EEG monitoring services: A survey among partners of the E-PILEPSY pilot network of reference for refractory epilepsy and epilepsy surgery.

Kobulashvili T, Höfler J, Dobesberger J, Ernst F, Ryvlin P, Cross JH, Braun K, Dimova P, Francione S, Hecimovic H, Helmstaedter C, Kimiskidis VK, Lossius MI, Malmgren K, Marusic P, Steinhoff BJ, Boon P, Craiu D, Delanty N, Fabo D, Gil-Nagel A, Guekht A, Hirsch E, Kalviainen R, Mameniskiené R, Özkara Ç, Seeck M, Rubboli G, Krsek P, Rheims S, Trinka E.

Seizure. 2016 May;38:38-45. doi: 10.1016/j.seizure.2016.03.009. Epub 2016 Apr 1.

34.

Current use of imaging and electromagnetic source localization procedures in epilepsy surgery centers across Europe.

Mouthaan BE, Rados M, Barsi P, Boon P, Carmichael DW, Carrette E, Craiu D, Cross JH, Diehl B, Dimova P, Fabo D, Francione S, Gaskin V, Gil-Nagel A, Grigoreva E, Guekht A, Hirsch E, Hecimovic H, Helmstaedter C, Jung J, Kalviainen R, Kelemen A, Kimiskidis V, Kobulashvili T, Krsek P, Kuchukhidze G, Larsson PG, Leitinger M, Lossius MI, Luzin R, Malmgren K, Mameniskiene R, Marusic P, Metin B, Özkara C, Pecina H, Quesada CM, Rugg-Gunn F, Rydenhag B, Ryvlin P, Scholly J, Seeck M, Staack AM, Steinhoff BJ, Stepanov V, Tarta-Arsene O, Trinka E, Uzan M, Vogt VL, Vos SB, Vulliémoz S, Huiskamp G, Leijten FS, Van Eijsden P, Braun KP; E-PILEPSY consortium.

Epilepsia. 2016 May;57(5):770-6. doi: 10.1111/epi.13347. Epub 2016 Mar 25.

35.

Epilepsy after aneurysmal subarachnoid hemorrhage: A population-based, long-term follow-up study.

Huttunen JM, Kurki MI, von und zu Fraunberg M, Koivisto T, Ronkainen A, Rinne J, Jääskeläinen JE, Kalviainen R, Immonen A.

Neurology. 2015 Dec 1;85(22):1997. No abstract available.

PMID:
26962586
36.

Brivaracetam in Unverricht-Lundborg disease (EPM1): Results from two randomized, double-blind, placebo-controlled studies.

Kälviäinen R, Genton P, Andermann E, Andermann F, Magaudda A, Frucht SJ, Schlit AF, Gerard D, de la Loge C, von Rosenstiel P.

Epilepsia. 2016 Feb;57(2):210-21. doi: 10.1111/epi.13275. Epub 2015 Dec 15.

37.

Epilepsy priorities in Europe: A report of the ILAE-IBE Epilepsy Advocacy Europe Task Force.

Baulac M, de Boer H, Elger C, Glynn M, Kälviäinen R, Little A, Mifsud J, Perucca E, Pitkänen A, Ryvlin P.

Epilepsia. 2015 Nov;56(11):1687-95. doi: 10.1111/epi.13201. Epub 2015 Sep 28. Review.

38.

Temporal anteroinferior encephalocele: An underrecognized etiology of temporal lobe epilepsy?

Saavalainen T, Jutila L, Mervaala E, Kälviäinen R, Vanninen R, Immonen A.

Neurology. 2015 Oct 27;85(17):1467-74. doi: 10.1212/WNL.0000000000002062. Epub 2015 Sep 25.

PMID:
26408489
39.

Choice of the first anti-epileptic drug in elderly patients with newly diagnosed epilepsy: A Finnish retrospective study.

Bruun E, Virta LJ, Kälviäinen R, Keränen T.

Seizure. 2015 Sep;31:27-32. doi: 10.1016/j.seizure.2015.06.016. Epub 2015 Jul 4.

40.

Trigger Development for the Improvement of Neurological Patient Care.

Kivekäs E, Kinnunen UM, Haatainen K, Kälviäinen R, Saranto K.

Stud Health Technol Inform. 2015;216:1116.

PMID:
26262415
41.

Incidence and mortality of super-refractory status epilepticus in adults.

Kantanen AM, Reinikainen M, Parviainen I, Ruokonen E, Ala-Peijari M, Bäcklund T, Koskenkari J, Laitio R, Kälviäinen R.

Epilepsy Behav. 2015 Aug;49:131-4. doi: 10.1016/j.yebeh.2015.04.065. Epub 2015 Jul 2.

PMID:
26141934
42.

Progressive Myoclonus Epilepsies.

Kälviäinen R.

Semin Neurol. 2015 Jun;35(3):293-9. doi: 10.1055/s-0035-1552620. Epub 2015 Jun 10. Review.

PMID:
26060909
43.

Therapeutic misconception correlates with willingness to participate in clinical drug trials among patients with epilepsy; need for better counseling.

Reijula E, Halkoaho A, Pietilä AM, Selander T, Kälviäinen R, Keränen T.

Epilepsy Behav. 2015 Jul;48:29-34. doi: 10.1016/j.yebeh.2015.05.013. Epub 2015 May 31.

PMID:
26037846
44.

Intranasal therapies for acute seizures.

Kälviäinen R.

Epilepsy Behav. 2015 Aug;49:303-6. doi: 10.1016/j.yebeh.2015.04.027. Epub 2015 May 26. Review.

PMID:
26022649
45.

Forehead EEG electrode set versus full-head scalp EEG in 100 patients with altered mental state.

Muraja-Murro A, Mervaala E, Westeren-Punnonen S, Lepola P, Töyräs J, Myllymaa S, Julkunen P, Kantanen AM, Kälviäinen R, Myllymaa K.

Epilepsy Behav. 2015 Aug;49:245-9. doi: 10.1016/j.yebeh.2015.04.041. Epub 2015 May 18.

PMID:
25997637
46.

Transcranial Magnetic Stimulation Combined with EEG Reveals Covert States of Elevated Excitability in the Human Epileptic Brain.

Kimiskidis VK, Koutlis C, Tsimpiris A, Kälviäinen R, Ryvlin P, Kugiumtzis D.

Int J Neural Syst. 2015 Aug;25(5):1550018. doi: 10.1142/S0129065715500185. Epub 2015 Mar 18.

PMID:
25986753
47.

Epilepsy after aneurysmal subarachnoid hemorrhage: A population-based, long-term follow-up study.

Huttunen J, Kurki MI, von Und Zu Fraunberg M, Koivisto T, Ronkainen A, Rinne J, Jääskeläinen JE, Kälviäinen R, Immonen A.

Neurology. 2015 Jun 2;84(22):2229-37. doi: 10.1212/WNL.0000000000001643. Epub 2015 May 6.

PMID:
25948726
48.

Valproate in the treatment of epilepsy in girls and women of childbearing potential.

Tomson T, Marson A, Boon P, Canevini MP, Covanis A, Gaily E, Kälviäinen R, Trinka E.

Epilepsia. 2015 Jul;56(7):1006-19. doi: 10.1111/epi.13021. Epub 2015 May 16. Review.

49.

Non-invasive mapping of bilateral motor speech areas using navigated transcranial magnetic stimulation and functional magnetic resonance imaging.

Könönen M, Tamsi N, Säisänen L, Kemppainen S, Määttä S, Julkunen P, Jutila L, Äikiä M, Kälviäinen R, Niskanen E, Vanninen R, Karjalainen P, Mervaala E.

J Neurosci Methods. 2015 Jun 15;248:32-40. doi: 10.1016/j.jneumeth.2015.03.030. Epub 2015 Apr 3.

PMID:
25845482
50.

Refining the phenotype of Unverricht-Lundborg disease (EPM1): a population-wide Finnish study.

Hyppönen J, Äikiä M, Joensuu T, Julkunen P, Danner N, Koskenkorva P, Vanninen R, Lehesjoki AE, Mervaala E, Kälviäinen R.

Neurology. 2015 Apr 14;84(15):1529-36. doi: 10.1212/WNL.0000000000001466. Epub 2015 Mar 13.

PMID:
25770194

Supplemental Content

Loading ...
Support Center